ZTS May 21, 2026ZTSConferences/Events
Zoetis to Participate in Upcoming Investor Conferences
Zoetis is set to participate in several upcoming investor conferences. Details regarding the specific conferences and the content of their presentations have not been disclosed in the article. This participation indicates Zoetis's ongoing engagement with investors and stakeholders in the biopharma sector.
Read more →
ZTS May 20, 2026ZTSGeneral
Zoetis Declares Third Quarter 2026 Dividend
Zoetis has announced its third quarter dividend for 2026. The declaration is part of the company's ongoing commitment to return value to its shareholders. Further details about the dividend amount and payment date were not provided in the announcement.
Read more →
ZTS May 20, 2026ZTSBackfill
Media Contacts Investor Contacts Jennifer Albano Steve Frank 1-862-399-0810 (o) 1-973-822-7141 (o) jennifer.albano zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) la
Read more →
ZTS May 7, 2026ZTSGeneral
Zoetis Announces First Quarter 2026 Results
Zoetis Inc. reported its Q1 2026 financial results, showing a 3% revenue increase to $2.3 billion, with net income at $601 million. The U.S. segment faced challenges, with an 8% revenue decline due to heightened competition and price sensitivity among pet owners. In contrast, the International segment saw a 17% revenue increase, driven by strong demand for companion animal products. The company remains optimistic about its pipeline of potential blockbusters and ongoing innovation efforts.
Read more →
ZTS May 7, 2026ZTSBackfill
Zoetis Announces First Quarter 2026 Results Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis Adjusted Net Income o
Read more →
ZTS Apr 2, 2026ZTSConferences/Events
Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results
Zoetis has announced a webcast and conference call to discuss its financial results for the first quarter of 2026. The event aims to provide insights into the company's performance during this period. Further details regarding the timing and access to the call will likely be shared closer to the date.
Read more →
ZTS Mar 5, 2026ZTSConferences/Events
Zoetis to Participate in Upcoming March 2026 Investor Conferences
Zoetis Inc. has announced that Wetteny Joseph, the CFO, will participate in upcoming investor conferences in March 2026. Interested parties can access live audio webcasts of the presentations through the Zoetis investor website, with replays available afterward. This participation highlights Zoetis's commitment to engaging with investors and sharing insights about its operations.
Read more →
ZTS Mar 2, 2026ZTSGeneral
Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation
Zoetis Inc. has announced its agreement to acquire Neogen's animal genomics business for $160 million. This acquisition aims to enhance Zoetis' Precision Animal Health portfolio by integrating advanced genomic technologies. The deal is expected to close in the second half of 2026, pending regulatory approvals. The acquisition will bolster Zoetis' commitment to livestock innovation and customer value.
Read more →
ZTS Feb 24, 2026ZTSConferences/Events
Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit
Zoetis Inc. will participate in the Bank of America Securities 2026 Animal Health Summit on February 26, 2026. Wetteny Joseph, the Executive Vice President and CFO, will represent the company during the event. Interested parties can access a live audio webcast and a replay will be available afterward on Zoetis' website.
Read more →
ZTS Feb 12, 2026ZTSGeneral
Zoetis Reports Fourth Quarter and Full Year 2025 Results
Zoetis Inc. reported strong financial results for Q4 and full year 2025, with revenues of $2.4 billion and $9.5 billion, respectively. The company highlighted growth in adjusted net income and successful regulatory approvals for new osteoarthritis pain products. Looking ahead, Zoetis provided guidance for 2026 and emphasized its commitment to innovation and market expansion.
Read more →
ZTS Dec 30, 2025ZTSConferences/Events
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
Zoetis Inc. will host a webcast and conference call on February 12, 2026, to discuss its fourth quarter and full year 2025 financial results. CEO Kristin Peck and CFO Wetteny Joseph will present the results and answer questions from analysts. The event will be accessible to the public via the company's investor website.
Read more →
ZTS Dec 2, 2025ZTSConferences/Events
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
Zoetis Inc. hosted an Innovation Webcast to discuss its R&D leadership and growth opportunities in animal health. CEO Kristin Peck emphasized the company's commitment to innovation and the importance of animals in society. The webcast featured key executives and showcased Zoetis's plans to advance therapies and solutions for animal care.
Read more →
ZTS Nov 4, 2025ZTSBackfill
Zoetis Announces Third Quarter 2025 Results Reports Revenue of $2.4 Billion, Growing 1%, and Net Income of $721 Million, or $1.63 per Diluted Share, Increasing 6% and 9%, Respectively, on a Reported Basis for Third Quart
Read more →
ZTS Aug 5, 2025ZTSBackfill
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook Reports Revenue of $2.5 Billion, Growing 4%, and Net Income of $718 Million, or $1.61 per Diluted Share, Increasing 15% and 18%, Respectively, o
Read more →
ZTS May 6, 2025ZTSBackfill
Zoetis Announces First Quarter 2025 Results Reports Revenue of $2.2 Billion, Growing 1%, and Net Income of $631 Million, or $1.41 per Diluted Share, Increasing 5% and 8%, Respectively, on a Reported Basis for First Quart
Read more →
ZTS Feb 13, 2025ZTSBackfill
Zoetis Reports Fourth Quarter and Full Year 2024 Results Reports Revenue of $2.3 Billion, Growing 5%, and Net Income of $581 Million, or $1.29 per Diluted Share, Increasing 11% and 13%, Respectively, on a Reported Basis
Read more →
ZTS Feb 6, 2025ZTSBackfill
Media Contacts Investor Contacts Jennifer Albano Steve Frank 1-973-945-4333 (o) 1-973-822-7141 (o) jennifer.albano zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) la
Read more →
ZTS Nov 4, 2024ZTSBackfill
Zoetis Announces Third Quarter 2024 Results Reports Revenue of $2.4 Billion, Growing 11%, and Net Income of $682 Million, or $1.50 per Diluted Share, Increasing 14% and 16%, Respectively, on a Reported Basis for Third Qu
Read more →
ZTS Oct 10, 2024ZTSBackfill
Media Contacts Investor Contacts Jennifer Albano Steve Frank 1- 862-399-0810 (o) 1-973-822-7141 (o) jennifer.albano zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) l
Read more →
ZTS Aug 6, 2024ZTSBackfill
Zoetis Announces Second Quarter 2024 Results Reports Revenue of $2.4 Billion, Growing 8%, and Net Income of $624 Million, or $1.37 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for Second Qua
Read more →
ZTS May 22, 2024ZTSBackfill
Media Contacts Investor Contacts Jenielle Alonso Steve Frank 1-973-945-4333 (o) 1-973-822-7141 (o) jenielle.alonso zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) la
Read more →
ZTS May 2, 2024ZTSBackfill
Zoetis Announces First Quarter 2024 Results Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Qua
Read more →
ZTS Feb 13, 2024ZTSBackfill
Zoetis Reports Fourth Quarter and Full Year 2023 Results For Fourth Quarter 2023, Zoetis Reports Revenue of $2.2 Billion, Growing 8%, and Net Income of $525 Million, or $1.14 per Diluted Share, Increasing 14% and 15%, Re
Read more →
ZTS Feb 6, 2024ZTSBackfill
Media Contacts Investor Contacts Jenielle Alonso Steve Frank 1-973-945-9333 (o) 1-973-822-7141 (o) jenielle.alonso zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) la
Read more →
ZTS Dec 7, 2023ZTSBackfill
Media Contacts Investor Contacts Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.price zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) laura.pan
Read more →
ZTS Nov 2, 2023ZTSBackfill
Zoetis Announces Third Quarter 2023 Results Reports Revenue of $2.2 Billion, Growing 7%, and Net Income of $596 Million, or $1.29 per Diluted Share, Increasing 13% and 14%, Respectively, on a Reported Basis for Third Qua
Read more →
ZTS Oct 12, 2023ZTSBackfill
Media Contacts Investor Contacts Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.price zoetis.com steve.frank zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (c) 1-973-443-2792 (o) laura.pan
Read more →
ZTS Aug 8, 2023ZTSBackfill
Zoetis Announces Second Quarter 2023 Results Reports Revenue of $2.2 Billion, Growing 6%, and Net Income of $671 Million, or $1.45 per Diluted Share, Increasing 27% and 29%, Respectively, on a Reported Basis for Second Q
Read more →
ZTS May 11, 2023ZTSBackfill
Media Contacts Investor Contacts Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.price zoetis.com steve.frank zoetis.com Kristen Seely Nick Soonthornchai 1-973-443-2777 (o) 1-973-443-2792 (o) kristen
Read more →
ZTS May 4, 2023ZTSBackfill
Zoetis Announces First Quarter 2023 Results Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quart
Read more →
ZTS Feb 14, 2023ZTSBackfill
Zoetis Reports Fourth Quarter and Full Year 2022 Results For Fourth Quarter 2022, Zoetis Reports Revenue of $2.0 Billion, Growing 4%, and Net Income of $461 Million, or $0.99 per Diluted Share, on a Reported Basis Delive
Read more →
ZTS Nov 3, 2022ZTSBackfill
Zoetis Announces Third Quarter 2022 Results Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $529 Million, or $1.13 per Diluted Share, Decreasing 4% and 3%, Respectively, on a Reported Basis for Third Quart
Read more →
ZTS Oct 13, 2022ZTSBackfill
Document Media Contacts Investor Contacts Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.price zoetis.com steve.frank zoetis.com Kristen Seely Nick Soonthornchai 1-973-443-2777 (o) 1-973-443-2792 (o
Read more →
ZTS Aug 4, 2022ZTSBackfill
Zoetis Announces Second Quarter 2022 Results Reports Revenue of $2.1 Billion, Growing 5%, and Net Income of $529 Million, or $1.12 per Diluted Share, Increasing 3% and 5%, Respectively, on a Reported Basis for Second Qua
Read more →
ZTS May 5, 2022ZTSBackfill
Zoetis Announces First Quarter 2022 Results Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quart
Read more →
ZTS Feb 15, 2022ZTSBackfill
Zoetis Reports Fourth Quarter and Full Year 2021 Results For Fourth Quarter 2021, Zoetis Reports Revenue of $2.0 Billion, Growing 9%, and Net Income of $414 Million, or $0.87 per Diluted Share, on a Reported Basis Report
Read more →
ZTS Nov 4, 2021ZTSBackfill
Zoetis Announces Third Quarter 2021 Results Reports Revenue of $2.0 Billion, Growing 11%, and Net Income of $552 Million, or $1.16 per Diluted Share, Increasing 15% and 16%, Respectively, on a Reported Basis for Third Qu
Read more →
ZTS Oct 18, 2021ZTSBackfill
FOR IMMEDIATE RELEASE Media Contacts: Investor Contacts: Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.price@zoetis.com steve.frank@zoetis.com Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-822-
Read more →
ZTS Aug 5, 2021ZTSBackfill
Zoetis Announces Second Quarter 2021 Results Reports Revenue of $1.9 Billion, Growing 26%, and Net Income of $512 Million, or $1.07 per Diluted Share, Increasing 36% and 35%, Respectively, on a Reported Basis for Second
Read more →
ZTS May 11, 2021ZTSBackfill
FOR IMMEDIATE RELEASE Media Contacts : Investor Contacts : Bill Price Steve Frank 1-973-443-2742 (o) 1-973-822-7141 (o) william.price@zoetis.com steve.frank@zoetis.com Kristen Seely Keith Gaub 1-973-443-2777 (o) 1-973-82
Read more →
ZTS May 6, 2021ZTSBackfill
Zoetis Announces First Quarter 2021 Results Reports Revenue of $1.9 Billion, Growing 22%, and Net Income of $559 Million, or $1.17 per Diluted Share, Increasing 32% and 33%, Respectively, on a Reported Basis for First Qu
Read more →
ZTS Feb 16, 2021ZTSBackfill
Zoetis Reports Fourth Quarter and Full Year 2020 Results For Fourth Quarter 2020, Zoetis Reports Revenue of $1.8 Billion, Growing 8%, and Net Income of $359 Million, or $0.75 per Diluted Share, on a Reported Basis Report
Read more →
ZTS Nov 5, 2020ZTSBackfill
Zoetis Announces Third Quarter 2020 Results Reports Revenue of $1.8 Billion, Growing 13%, and Net Income of $479 Million, or $1.00 per Diluted Share, Both Increasing 11% on a Reported Basis, for Third Quarter 2020 Report
Read more →
ZTS Aug 6, 2020ZTSBackfill
Zoetis Announces Second Quarter 2020 Results Reports Flat Revenue of $1.5 Billion, and Net Income of $377 Million, or $0.79 per Diluted Share, Increasing 2% and 3%, Respectively, on a Reported Basis for Second Quarter 20
Read more →
ZTS May 6, 2020ZTSBackfill
Zoetis Announces First Quarter 2020 Results Reports Revenue of $1.5 Billion, Growing 5%, and Net Income of $423 Million, or $0.88 per Diluted Share, Increasing 36% and 35%, Respectively, on a Reported Basis for First Qua
Read more →
ZTS Feb 13, 2020ZTSBackfill
Zoetis Reports Fourth Quarter and Full Year 2019 Results For Fourth Quarter 2019, Zoetis Reports Revenue of $1.7 Billion, Growing 7%, and Net Income of $384 Million, or $0.80 per Diluted Share, on a Reported Basis Report
Read more →
ZTS Feb 11, 2020ZTSBackfill
FOR IMMEDIATE RELEASE
Read more →